LILLY NEUROSCIENCE
Details of failed studies cast pall on Novo Nordisk's GLP-1 as Alzheimer's treatmentThe joint studies showed some improvement in a few biological measures of the disease, but most of the changes were small and not enough to...04 Dec, 2025, 08.54 AM IST- Eli Lilly pops patent pep pill, to launch latest drugsEncouraged by the introduction of the product patent regime, US-based Eli Lilly & Company is planning to introduce a range of new drugs in ...10 May, 2007, 04.00 AM IST
Load More